US Stocks
/
Atossa Therapeutics, Inc. Share Price

Atossa Therapeutics, Inc. Share Price

NASDAQ: ATOS | Micro Cap
$2.42
+$0.00 (0.21%) Last updated on 10 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atossa Therapeutics, Inc. Stock Performance

Open
$2.50
Prev. Close
$2.42
Circuit Range
N/A
Day Range
$2.18 - $2.70
Year Range
$0.53 - $7.50
Volume
4,241
Average Traded
$2.49

Atossa Therapeutics, Inc. Share Price Today

As of 11 October 2026, Atossa Therapeutics, Inc.'s share price is $2.42. The stock opened at $2.50, compared to its previous close of $2.42. During today's trading session, Atossa Therapeutics, Inc.'s share price traded between $2.18 and $2.70, with an average price of $2.44. Over the past 52 weeks, the stock has recorded a high of $7.50 and a low of $0.53. In terms of performance, Atossa Therapeutics, Inc.'s share price has declined by 55.34% over the last six months and is up 173.09% on a year-on-year basis.

Atossa Therapeutics, Inc. Share Price Chart

$2.18$2.70
L
Show Current Price
H

Atossa Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$20.88M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.78
Revenue (TTM)
$0.00
Return On Equity (TTM)
-140.55%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
2.30%

Atossa Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.69-$10.94-$9.59-$8.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-25.89%12.34%11.47%

Atossa Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.96-$30.09-$25.50-$34.77
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-11.61%15.25%-36.35%

About Atossa Therapeutics, Inc.

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Atossa Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.04
$2.41
+22.96%
Sep 2026
$2.44
$1.96
-25.19%
Aug 2026
$2.14
$2.62
+27.80%
Jul 2026
$1.94
$2.05
+5.94%
Jun 2026
$5.17
$1.94
-62.61%
May 2026
$5.87
$5.17
-4.70%
Apr 2026
$5.25
$5.43
+7.21%
Mar 2026
$4.30
$5.07
+16.17%
Feb 2026
$6.93
$4.36
+673.05%
Jan 2026
$0.60
$0.56
-3.42%
Dec 2025
$0.77
$0.58
-24.94%
Nov 2025
$0.89
$0.78
-12.39%

ATOS Share Price FAQs

What is Atossa Therapeutics, Inc. share price today?

chevron-up
Atossa Therapeutics, Inc. share price today is $2.42 as on October 10, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Atossa Therapeutics, Inc. stock?

chevron-up
The 52 week high of Atossa Therapeutics, Inc. stock is $7.50, while the 52 week low is $0.53 as of 10 Oct '26.

What is ATOS's market capitalisation today?

chevron-up
ATOS market capitalisation is $20.88M as of October 11, 2026, at 2:06 am IST.

What is ATOS's net income for the last quarter?

chevron-up
ATOS's net income for the last quarter is -8.49B USD.

What is the 5 year returns of ATOS?

chevron-up
The 5 year returns of ATOS is -5.83% as on 10 Oct '26.

What is the high & low stock price of ATOS today?

chevron-up
ATOS stock price hit a high of $2.70 and low of $2.18 as of 10 Oct '26.

Can I buy ATOS shares in India?

chevron-up
Yes. You can buy ATOS in India by opening an international trading account.